Application of Evidence-Based Medical Therapy Is Associated With Improved Outcomes After Percutaneous Coronary Intervention and Is a Valid Quality Indicator
Wissam A. Jaber, MD,
Ryan J. Lennon, MS,
Verghese Mathew, MD,
David R. Holmes, Jr, MD,
Amir Lerman, MD and
Charanjit S. Rihal, MD, MBA*
Mayo Clinic, Rochester, Minnesota
View larger version (15K):
[in a new window]
|
Figure 1 Kaplan-Meier curve for adjusted myocardial infarction-free survival according to medication score (MEDS). Relative to MEDS 0 to 1 curve, the p values for MEDS 2, 3, and 4 curves are 0.15, 0.006, and 0.002, respectively. The numbers below the curves are the number of patients at risk for each year of follow-up.
|
|
|
